← Back to search
SPAULDING CLINICAL RESEARCH, LLC
WEST BEND, WI, 53095
UnclaimedClaim this profile (free)
Prime contracting experience
4 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Health and Human Services Food and Drug Administration | CLINICAL PHARMACOLOGY STUDIES | 75F40119D10032USAspending | $6,000,321 | Jan 7, 2025 | Sep 28, 2023 – Mar 28, 2026 |
| Prime | Department of Health and Human Services Food and Drug Administration | CLINICAL AND LABORATORY APPLIED REGULATORY SCIENCE | 75F40119D10032USAspending | $5,454,072 | Jan 6, 2025 | Sep 29, 2020 – Mar 26, 2026 |
| Prime | Department of Health and Human Services Food and Drug Administration | OFFICE OF CLINICAL PHARMACOLOGY - NEW TASK ORDER #4 AGAINST SPAULDING CLINICAL STUDIES IDIQ 75F40119D10032 - CLINICAL ECG STUDIES TO EVALUATE ELECTROPHYSIOLOGICAL EFFECTS OF POTENTIAL QT PROLONGING DRUGS WITH NOVEL ECG BIOMARKERS | 75F40119D10032USAspending | $1,429,138 | Sep 14, 2023 | Sep 10, 2021 – Oct 10, 2024 |
| Prime | Department of Health and Human Services Food and Drug Administration | CLINICAL AND LABORATORY APPLIED REGULATORY SCIENCE | 75F40119D10032USAspending | $6,561,387 | Jun 23, 2023 | Sep 23, 2019 – Sep 26, 2024 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Health and Human ServicesGov-sourced
Government-sourced data comes from SAM.gov, SBA and USAspending.gov and is attributed to its source. Items marked company-reported were provided by the company and are verified by FedSub only where labeled. FedSub is a private company and is not affiliated with SBA, GSA/SAM.gov, or any government agency.